Document is current
Any future updates will be listed below
-
Authors
López-Martínez, Cecilia
Martín-Vicente, Paula
Amado-Rodríguez, Laura
López-Alonso, Inés
Fernández-Rodríguez, Margarita
González-López, Adrián
Martínez-Camblor, Pablo
Gómez, Juan
Boyle, Andrew J.
O’Kane, Cecilia M.
McAuley, Daniel F.
Tsoporis, James N.
dos Santos, Claudia
Albaiceta, Guillermo M. https://orcid.org/0000-0002-9276-3253
-
Funding
Funding for this research was provided by:
Centro de Investigación Biomedica en Red-Enfermedades respiratorias (CB17/06/00021)
Gobierno del Principado de Asturias (AYUD/2021/52014)
Gobierno del Principado de Asturias (AYUD/2022/33523)
Gobierno del Principado de Asturias (IDE/2024/000797)
Ministerio de Universidades (FPU18/02965)
Instituto de Salud Carlos III (JR22/00066)
Instituto de Salud Carlos III (FI21/00168)
Ministerio de Ciencia e Innovación (PRX19/00175)
- License Information
-
More Information
Article History
Received: 21 April 2025
Accepted: 27 May 2025
First Online: 7 June 2025
Declarations
:
: The use of human lungs not suitable for transplantation was approved by the London Central Research Ethics Committee (project reference 14/LO/0250). The use of BALF samples from patients was approved by the Regional Ethics Committee (Comité de ética de la investigación Clinica del Principado de Asturias, Spain, reference 22/17). The remaining data used were publicly available. Written informed consent was obtained from each participant’s next of kin.
: Not applicable.
: CLM, PMV, ILA, LAR, CCdS and GMA are inventors of a patent co-owned by Fundación para la Investigación e Innovación Biosanitaria en el Principado de Asturias (FINBA), Centro para la Investigación Biomédica en Red (CIBER), Universidad de Oviedo and Unity Health Toronto, focused on the use of micro-RNAs to detect lung overdistension. MF, AGL, PMC, AB, CO, DFM, JT and JG have no conflicts of interest to disclose.
